Venus Medtech still seeking cure for governance problems
The transcatheter maker’s shares were suspended last November, and it must still meet several conditions from the Hong Kong Stock Exchange before trading can resume Key Takeways: Venus Medtech disclosed…
2500.HK
Recent Articles
RELATED ARTICLES
-
FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales
2500.HK
-
Yiren finds big returns in small-loan focus, even as headwinds swirl
YRD.US
- CHINA BULLETIN: Services, Trade Send Positive Signals
- CHINA BULLETIN: China Economy Off to Strong Start in 2024
- CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
Discover hidden China stock gems in our weekly newsletter